ID
44999
Beskrivning
Principal Investigator: Richard Gilbertson, St. Jude Children's Research Hospital, Memphis, TN, USA MeSH: Medulloblastoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000409 Medulloblastoma is a heterogenous disease made up of at least four distinct subtypes of disease which appear to exploit and disrupt naturally occurring developmental pathways of cellular growth and hindbrain development. To better understand the driver mutations of this disease, we performed whole genome sequencing of 37 medulloblastomas and the corresponding normal DNA of the 37 affected children treated at St. Jude Children's Research Hospital. We have found several novel mutations which appear subtype specific. These mutations were checked for frequency in a separate tumor cohort of 56 children with medulloblastoma, also treated on the St. Jude Medulloblastoma 2003 trial, and were tested in several animal models of medulloblastoma for proof of oncogenic potential.
Länk
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000409
Nyckelord
Versioner (2)
- 2022-07-01 2022-07-01 - Dr. Christian Niklas
- 2022-10-12 2022-10-12 - Adrian Schulz
Rättsinnehavare
Richard Gilbertson, St. Jude Children's Research Hospital, Memphis, TN, USA
Uppladdad den
1 juli 2022
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000409 Sequencing of Medulloblastoma
Subject ID, consent group, subject source, subject source ID, and affection status of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Subject ID, gender, age at diagnosis, ethnicity, sample description, patient relapse, if patient received bone marrow transplant, genetic lesions, primary protocol of treatment, and disease code of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, analyte type, tumor status, body site where sample was collected, primary tumor location, and histological type of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID and GEO accession ID of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
Similar models
Subject ID, consent group, subject source, subject source ID, and affection status of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Subject ID, gender, age at diagnosis, ethnicity, sample description, patient relapse, if patient received bone marrow transplant, genetic lesions, primary protocol of treatment, and disease code of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, analyte type, tumor status, body site where sample was collected, primary tumor location, and histological type of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID and GEO accession ID of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
C1257890 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C0449438 (UMLS CUI [1,2])
C0009932 (UMLS CUI [2,1])
C0449438 (UMLS CUI [2,2])